Integer Holdings Corp (ITGR) stock
ITGRNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Oct 2, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3023% above fair value
$126.42−0.26 (-0.21%)
Close on Nov 12, 2026Market cap $4.30BP/E 42.4Yield –
Integer r&d expenses
Research and development expenses are spending on new products and technology.
Integer's R&D Expenses for the twelve months ending Oct 2, 2026 was $51.16M, up 2.3% year over year. For fiscal 2025 it was $49.50M, down 7.3% from the year before. Over ten years it grew -0.7% a year on average. The highest annual figure on record is $61.97M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $49.50M | -7.3% |
| FY2024 | Dec 31, 2024 | $53.43M | -13.8% |
| FY2023 | Dec 31, 2023 | $61.97M | +3.7% |
| FY2022 | Dec 31, 2022 | $59.76M | +15.0% |
| FY2021 | Dec 31, 2021 | $51.99M | +7.3% |
| FY2020 | Dec 31, 2020 | $48.47M | +4.2% |
| FY2019 | Dec 31, 2019 | $46.53M | -4.3% |
| FY2018 | Dec 28, 2018 | $48.60M | -0.5% |
| FY2017 | Dec 29, 2017 | $48.85M | +2.0% |
| FY2016 | Dec 30, 2016 | $47.90M | -9.6% |
| FY2015 | Jan 1, 2016 | $53.00M | +6.3% |
| FY2014 | Jan 2, 2015 | $49.85M | -7.8% |
| FY2013 | Jan 3, 2014 | $54.08M | +3.0% |
| FY2012 | Dec 28, 2012 | $52.49M | +15.3% |
| FY2011 | Dec 30, 2011 | $45.51M | +1.1% |
| FY2010 | Dec 31, 2010 | $45.02M | +34.1% |
| FY2009 | Jan 1, 2010 | $33.56M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Oct 2, 2026 | $13.53M | +23.6% |
| Q2 FY2026 | Jul 3, 2026 | $11.28M | -20.8% |
| Q1 FY2026 | Apr 3, 2026 | $16.24M | +14.4% |
| Q4 FY2025 | Dec 31, 2025 | $10.11M | -4.8% |
| Q3 FY2025 | Sep 26, 2025 | $10.95M | -8.2% |
| Q2 FY2025 | Jun 27, 2025 | $14.24M | -8.8% |
| Q1 FY2025 | Mar 28, 2025 | $14.20M | -7.0% |
| Q4 FY2024 | Dec 31, 2024 | $10.61M | -18.7% |
| Q3 FY2024 | Sep 27, 2024 | $11.92M | -15.2% |
| Q2 FY2024 | Jun 28, 2024 | $15.61M | -7.5% |
| Q1 FY2024 | Mar 29, 2024 | $15.27M | -20.0% |
| Q4 FY2023 | Dec 31, 2023 | $13.05M | +2.9% |
| Q3 FY2023 | Sep 29, 2023 | $14.07M | -12.7% |
| Q2 FY2023 | Jun 30, 2023 | $16.88M | +13.5% |
| Q1 FY2023 | Mar 31, 2023 | $19.09M | +18.7% |
| Q4 FY2022 | Dec 31, 2022 | $12.69M | -0.4% |
| Q3 FY2022 | Sep 30, 2022 | $16.12M | +33.8% |
| Q2 FY2022 | Jul 1, 2022 | $14.87M | +8.2% |
| Q1 FY2022 | Apr 1, 2022 | $16.08M | +19.5% |
| Q4 FY2021 | Dec 31, 2021 | $12.74M | +20.3% |
| Q3 FY2021 | Oct 1, 2021 | $12.05M | +1.3% |
| Q2 FY2021 | Jul 2, 2021 | $13.74M | +7.8% |
| Q1 FY2021 | Apr 2, 2021 | $13.46M | +1.7% |
| Q4 FY2020 | Dec 31, 2020 | $10.59M | -10.3% |
| Q3 FY2020 | Oct 2, 2020 | $11.89M | +1.4% |
| Q2 FY2020 | Jul 3, 2020 | $12.75M | +11.8% |
| Q1 FY2020 | Apr 3, 2020 | $13.24M | +14.2% |
| Q4 FY2019 | Dec 31, 2019 | $11.81M | +16.2% |
| Q3 FY2019 | Sep 27, 2019 | $11.73M | -4.1% |
| Q2 FY2019 | Jun 28, 2019 | $11.40M | -11.9% |
| Q1 FY2019 | Mar 29, 2019 | $11.60M | -12.7% |
| Q4 FY2018 | Dec 28, 2018 | $10.16M | -26.1% |
| Q3 FY2018 | Sep 28, 2018 | $12.23M | +0.1% |
| Q2 FY2018 | Jun 29, 2018 | $12.94M | +15.1% |
| Q1 FY2018 | Mar 30, 2018 | $13.28M | -1.0% |
| Q4 FY2017 | Dec 29, 2017 | $13.75M | +148.1% |
| Q3 FY2017 | Sep 29, 2017 | $12.23M | – |
| Q2 FY2017 | Jun 30, 2017 | $11.24M | – |
| Q1 FY2017 | Mar 31, 2017 | $13.41M | – |
| Q4 FY2016 | Dec 30, 2016 | $5.54M | – |
See a number that looks wrong?